Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Achtste van wereldbevolking heeft hepatitis E-antistoffen
jan 2021 | Hepatitis, Virale infecties